Our Story

At BioPocrates, we are on a mission to restore and revitalize human health and wellness through the power of our all-natural, fermented probiotics. Like Hippocrates, we value the profound impact of food in its purest form and the philosophy that most disease begins in the gut.  

Zoguri, our L. reuteri yogurt-based supplement, is crafted naturally to replenish what could be missing in the digestive system. The seven species of beneficial bacteria in Zoguri, including two strains of L. reuteri—a beneficial keystone species that 96% of modern-day humans lack¹—have been clinically shown to promote healthy digestion², lessen symptoms of constipation³ and IBS⁴, support immunity⁵ and bone health⁶, and reduce stress⁷, anxiety⁷, and inflammation⁸. 

Unlike other probiotic supplements and pill alternatives, Zoguri is hand-crafted, with a long fermentation process. This ensures a consistent, yogurt-like taste packed with essential bacteria. With no additives or synthetic compounds, just two tablespoons a day could make a noticeable difference.   

Replenish what's missing and experience the daily support your gut microbiome deserves. How will you revitalize with Zoguri? 

 

 

 

¹ Molin, G., Jeppsson, B., Johansson, M. L., et al. (1993). Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. Journal of Applied Bacteriology, 74(3), 314-323. doi: 10.1111/j.1365-2672.1993.tb03031.x 

² Gao, Huijuan et al. “The Functional Roles of Lactobacillus acidophilus in Different Physiological and Pathological Processes.” Journal of microbiology and biotechnology vol. 32,10 (2022): 1226-1233. doi:10.4014/jmb.2205.05041 

³ Riezzo, G., A. Orlando, B. D’Attoma, M. Linsalata, M. Martulli, and F. Russo. "Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation". Beneficial Microbes 9.1 (2018): 51-60. https://doi.org/10.3920/BM2017.0049 Web 

⁴ Cruchet, S., Hirsch, S., Villa-López, D., et al. "Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial." Frontiers in Gastroenterology, 2024, article 1296048. doi: 10.3389/fgstr.2023.1296048 

⁵ Tubelius, Py et al. “Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study.” Environmental health : a global access science source vol. 4 25. 7 Nov. 2005, doi:10.1186/1476-069X-4-25 

⁶ Nilsson, A. G., Sundh, D., Bäckhed, F., & Lorentzon, M. "Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial." Journal of Internal Medicine, vol. 284, no. 3, 2018, pp. 307-317. doi: 10.1111/joim.12805 

⁷ Schaub, A. C., Schneider, E., Vazquez-Castellanos, J. F., et al. (2022). Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial. Translational Psychiatry, 12, article 227. https://doi.org/10.1038/s41398-022-01977-z 

⁸ Li, Peishun et al. “One-year supplementation with Lactobacillus reuteri ATCC PTA 6475 counteracts a degradation of gut microbiota in older women with low bone mineral density.” NPJ biofilms and microbiomes vol. 8,1 84. 19 Oct. 2022, doi:10.1038/s41522-022-00348-2